A new consortium of banks to store biological samples for cancer research has been announced at the National Cancer Research Institute Cancer Conference in Birmingham.
At present - and especially where rare cancers are concerned - it is difficult to answer some of the most pressing research questions using samples from a single bank, as the numbers available are too small.
Different banks may also use different methods to prepare and preserve material, meaning that consistency can be affected when using samples from multiple sources.
The Confederation of Cancer Biobanks (CCB) will work toward common standards and practices and tackle other issues affecting cancer research using human samples.
"The Confederation of Cancer Biobanks will greatly boost cancer research in the UK," said Dr Brian Clark, chief executive of founding member onCore UK.
It will lead, for the first time in this country, to the use of common standards for the custodianship of the precious cancer tissues that patients donate.
"Also, by providing access to larger numbers of high quality samples, the CCB will make possible many important research studies that have historically been difficult to carry out," Dr Clark added.
The CCB has been formed out of collaboration by Tayside Tissue Bank, the Glasgow Biobank, the Wales Cancer Bank and onCore UK.
Membership will be open to any institution that manages a cancer tissue bank and is willing to adopt the common standards and practices used by CCB members.
Stomach bacteria may prevent some oesophageal cancers
"Research needed" to develop breast cancer prevention drug
India bans smoking in public places
Vitamin C may reduce effectiveness of anti-cancer drugs
Black men face higher prostate cancer risk
Tobacco products to carry stark picture warnings
Low-cost test for hereditary breast cancer could soon be available
Study uncovers commercial links between early Hollywood and tobacco firms
Cancer drug availability varies widely across the UK
Cancer patients to get free prescriptions